Effectiveness of interleukin-17A inhibitors in patients with ankylosing spondylitis: A protocol for systematic review and meta-analysis

Ankylosing spondylitis is a chronic immune-mediated inflammatory arthritis. Interleukin-17A (IL-17A) inhibitors is recognized as a novel therapeutic target for ankylosing spondylitis. However, there is still a lack of high-quality research evidence regarding the issues. Therefore, we performed a pro...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Medicine (Baltimore) 2022-12, Vol.101 (49), p.e32224-e32224
Hauptverfasser:	Yan, Mingguang, Fang, Xiao, Guo, Jianjun, Yin, Weibing
Format:	Artikel
Sprache:	eng
Schlagworte:	Humans Interleukin-17 - antagonists & inhibitors Meta-Analysis as Topic Research Design Spondylitis, Ankylosing - drug therapy Study Protocol Systematic Review Systematic Reviews as Topic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!